Novonesis (0Q4U) Share Forecast & Price Target

14 Followers

See the Price Targets and Ratings of:

All Analysts

Top Analysts

Premium

0Q4U Analyst Ratings

Strong Buy

6 Buy

1 Hold

0 Sell

Based on 7 analysts giving stock ratings to

Novonesis

in the past 3 months

TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months

0Q4U Stock 12 Month Forecast

Average Price Target

kr500.00

▲(31.20% Upside)

Based on 7 Wall Street analysts offering 12 month price targets for Novonesis in the last 3 months. The average price target is kr500.00 with a high forecast of kr540.00 and a low forecast of kr415.00. The average price target represents a 31.20% change from the last price of kr381.10.

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"365":"kr365","409":"kr409","453":"kr453","497":"kr497","541":"kr541"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":540,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">kr540.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":500,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">kr500.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":415,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">kr415.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[365,409,453,497,541],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Nov<br/>2025","6":"Feb<br/>2026","9":"May<br/>2026","12":"Aug<br/>2026","25":"Aug<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,452.3,459.04615384615386,465.7923076923077,472.53846153846155,479.2846153846154,486.03076923076924,492.7769230769231,499.5230769230769,506.2692307692308,513.0153846153846,519.7615384615385,526.5076923076923,533.2538461538461,{"y":540,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,452.3,455.96923076923076,459.63846153846157,463.3076923076923,466.9769230769231,470.6461538461539,474.31538461538463,477.9846153846154,481.65384615384613,485.32307692307694,488.9923076923077,492.66153846153844,496.33076923076925,{"y":500,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,452.3,449.4307692307692,446.5615384615385,443.6923076923077,440.82307692307694,437.95384615384614,435.0846153846154,432.2153846153846,429.34615384615387,426.4769230769231,423.60769230769233,420.73846153846154,417.86923076923074,{"y":415,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":398.442,"date":1756674000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 11,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":386.206,"date":1759266000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 11,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":382.003,"date":1761948000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 8,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":394.312,"date":1764540000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":400.765,"date":1767218400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":376.589,"date":1769896800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":366.481,"date":1772316000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":386.193,"date":1774990800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 7,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":388.756,"date":1777582800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 11,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":375.012,"date":1780261200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 8,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":412.738,"date":1782853200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":419.805,"date":1785531600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 7,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":452.3,"date":1788210000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 7,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Highest Price Targetkr540.00

Average Price Targetkr500.00

Lowest Price Targetkr415.00

The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts

Marcus Dunford-Castro

Jefferies

kr480→kr540

Buy

41.70%

Upside

Reiterated

09/01/26

Jefferies Keeps Their Buy Rating on Novonesis (0Q4U)

Sebastian Bray

Berenberg Bank

kr422→kr500

Buy

31.20%

Upside

Reiterated

08/24/26

Novonesis price target raised to DKK 500 from DKK 422 at BerenbergNovonesis price target raised to DKK 500 from DKK 422 at Berenberg

Lisa De Neve

Morgan Stanley

kr520→kr535

Buy

40.38%

Upside

Reiterated

08/21/26

Morgan Stanley Sticks to Its Buy Rating for Novonesis (0Q4U)

Alex Sloane

Barclays

kr500

Buy

31.20%

Upside

Reiterated

08/20/26

Novonesis (0Q4U) Gets a Buy from Barclays

Chetan Udeshi

J.P. Morgan

kr500→kr520

Buy

36.45%

Upside

Reiterated

07/08/26

Novonesis price target raised to DKK 520 from DKK 500 at JPMorganNovonesis price target raised to DKK 520 from DKK 500 at JPMorgan

Nicola Tang

Exane BNP Paribas

Not Ranked

Exane BNP Paribas

kr362→kr415

Hold

8.90%

Upside

Upgraded

07/03/26

Novonesis upgraded to Neutral from Underperform at BNP ParibasNovonesis upgraded to Neutral from Underperform at BNP Paribas

Virginie Boucher-Ferte

Deutsche Bank

kr480→kr490

Buy

28.58%

Upside

Reiterated

06/30/26

Novonesis price target raised to DKK 490 from DKK 480 at Deutsche BankNovonesis price target raised to DKK 490 from DKK 480 at Deutsche Bank

Philip Ngotho

Kepler Capital

kr460

Buy

20.70%

Upside

Reiterated

05/18/26

Novonesis (0Q4U) Gets a Buy from Kepler Capital

Ranulf Orr

Citi

kr415→kr440

Buy

15.46%

Upside

Reiterated

05/08/26

Novonesis price target raised to DKK 440 from DKK 415 at CitiNovonesis price target raised to DKK 440 from DKK 415 at Citi

Artem Chubarov

Rothschild & Co Redburn

kr445

Buy

16.77%

Upside

Upgraded

03/27/26

Novonesis upgraded to Buy from Neutral at Rothschild & Co RedburnNovonesis upgraded to Buy from Neutral at Rothschild & Co Redburn

Georgina Fraser CFA

Goldman Sachs

kr550

Buy

44.32%

Upside

Reiterated

11/11/25

New Buy Rating for Novonesis (0Q4U), the Technology Giant

Charles Eden

UBS

kr470→kr445

Buy

16.77%

Upside

Reiterated

09/30/25

Novonesis (0Q4U): New Buy Recommendation for This Technology Giant

Analyst Type

Any

Human Analysts

Ranks

Any

Analyst Rating

Any

Upside/ Downside

Any

Action

Any

Marcus Dunford-Castro

Jefferies

kr480→kr540

Buy

41.70%

Upside

Reiterated

09/01/26

Jefferies Keeps Their Buy Rating on Novonesis (0Q4U)

Sebastian Bray

Berenberg Bank

kr422→kr500

Buy

31.20%

Upside

Reiterated

08/24/26

Novonesis price target raised to DKK 500 from DKK 422 at BerenbergNovonesis price target raised to DKK 500 from DKK 422 at Berenberg

Lisa De Neve

Morgan Stanley

kr520→kr535

Buy

40.38%

Upside

Reiterated

08/21/26

Morgan Stanley Sticks to Its Buy Rating for Novonesis (0Q4U)

Alex Sloane

Barclays

kr500

Buy

31.20%

Upside

Reiterated

08/20/26

Novonesis (0Q4U) Gets a Buy from Barclays

Chetan Udeshi

J.P. Morgan

kr500→kr520

Buy

36.45%

Upside

Reiterated

07/08/26

Novonesis price target raised to DKK 520 from DKK 500 at JPMorganNovonesis price target raised to DKK 520 from DKK 500 at JPMorgan

Nicola Tang

Exane BNP Paribas

Not Ranked

Exane BNP Paribas

kr362→kr415

Hold

8.90%

Upside

Upgraded

07/03/26

Novonesis upgraded to Neutral from Underperform at BNP ParibasNovonesis upgraded to Neutral from Underperform at BNP Paribas

Virginie Boucher-Ferte

Deutsche Bank

kr480→kr490

Buy

28.58%

Upside

Reiterated

06/30/26

Novonesis price target raised to DKK 490 from DKK 480 at Deutsche BankNovonesis price target raised to DKK 490 from DKK 480 at Deutsche Bank

Philip Ngotho

Kepler Capital

kr460

Buy

20.70%

Upside

Reiterated

05/18/26

Novonesis (0Q4U) Gets a Buy from Kepler Capital

Ranulf Orr

Citi

kr415→kr440

Buy

15.46%

Upside

Reiterated

05/08/26

Novonesis price target raised to DKK 440 from DKK 415 at CitiNovonesis price target raised to DKK 440 from DKK 415 at Citi

Artem Chubarov

Rothschild & Co Redburn

kr445

Buy

16.77%

Upside

Upgraded

03/27/26

Novonesis upgraded to Buy from Neutral at Rothschild & Co RedburnNovonesis upgraded to Buy from Neutral at Rothschild & Co Redburn

Georgina Fraser CFA

Goldman Sachs

kr550

Buy

44.32%

Upside

Reiterated

11/11/25

New Buy Rating for Novonesis (0Q4U), the Technology Giant

Charles Eden

UBS

kr470→kr445

Buy

16.77%

Upside

Reiterated

09/30/25

Novonesis (0Q4U): New Buy Recommendation for This Technology Giant

Stocks with the Highest Top Analyst Consensus in the General Sector

STDNStandard Nuclear

SKHYSK Hynix

ITGITG Inc. Class A

LIMENeutron Holdings, Inc.

EROCERock

Find stocks in the General sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Novonesis

3 Months

Charles EdenUBS

Success Rate

11/17 ratings generated profit

Average Return

+0.34%

Copying Charles Eden's trades and holding each position for 3 Months would result in 64.71% of your transactions generating a profit, with an average return of +0.34% per trade.

1 Year

Chetan UdeshiJ.P. Morgan

Success Rate

9/12 ratings generated profit

Average Return

+8.01%

Copying Chetan Udeshi's trades and holding each position for 1 Year would result in 75.00% of your transactions generating a profit, with an average return of +8.01% per trade.

2 Years

Chetan UdeshiJ.P. Morgan

Success Rate

12/12 ratings generated profit

Average Return

+12.38%

Copying Chetan Udeshi's trades and holding each position for 2 Years would result in 100.00% of your transactions generating a profit, with an average return of +12.38% per trade.

The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

0Q4U Analyst Recommendation Trends

Rating

Apr 26

May 26

Jun 26

Jul 26

Aug 26

Strong Buy

Buy

Hold

Sell

Strong Sell

total

In the current month, 0Q4U has received 7 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. 0Q4U average Analyst price target in the past 3 months is 500.00.

Each month's total comprises the sum of three months' worth of ratings.

0Q4U Financial Forecast

0Q4U Earnings Forecast

Next quarter’s earnings estimate for 0Q4U is kr5.87 with a range of kr4.19 to kr7.55. The previous quarter’s EPS was kr2.84. 0Q4U beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 50.49% of the time in the same period. In the last calendar year 0Q4U has Performed in-line its overall industry.

0Q4U Sales Forecast

Next quarter’s sales forecast for 0Q4U is kr8.58B with a range of kr8.49B to kr8.71B. The previous quarter’s sales results were kr8.34B. 0Q4U beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 63.25% of the time in the same period. In the last calendar year 0Q4U has Performed in-line its overall industry.

0Q4U Stock Forecast FAQ

What is GB:0Q4U’s average 12-month price target, according to analysts?

Based on analyst ratings, Novonesis’s 12-month average price target is 500.00.

What is GB:0Q4U’s upside potential, based on the analysts’ average price target?

Novonesis has 31.20% upside potential, based on the analysts’ average price target.

Can I see which stocks the top-ranking analysts are rating?

Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.

How can I follow the stock ratings of top Wall Street analysts?

Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.

Is Novonesis a Buy, Sell or Hold?

Novonesis has a consensus rating of Strong Buy, which is based on 6 buy ratings, 1 hold ratings and 0 sell ratings.

What is Novonesis’s share price target?

The average share price target for Novonesis is 500.00. This is based on 7 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst share price target is kr540.00 ,and the lowest forecast is kr415.00. The average share price target represents 31.20% Increase from the current price of kr381.1.

What do analysts say about Novonesis?

Novonesis’s analyst rating consensus is a Strong Buy. This is based on the ratings of 7 Wall Streets Analysts.

How can I buy shares of Novonesis?

To buy shares of GB:0Q4U, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.

Novonesis (0Q4U) Share Forecast & Price Target

0Q4U Analyst Ratings

0Q4U Stock 12 Month Forecast

Average Price Target

Detailed List of Analyst Forecasts​

Best Analysts Covering Novonesis

0Q4U Analyst Recommendation Trends

0Q4U Financial Forecast

0Q4U Earnings Forecast

0Q4U Sales Forecast

0Q4U Stock Forecast FAQ

Detailed List of Analyst Forecasts